Alnylam Pharmaceuticals Inc. will present a company overview and participate in a Q&A session at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at The Westin St. Francis in San Francisco. During the event, the company will unveil its new five-year strategy, provide updates on unaudited fourth quarter and full year 2025 global net product revenues, and offer an outlook for 2026 product sales. A live audio webcast of the presentation and Q&A session will be available on the Alnylam website.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alnylam Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260105374495) on January 05, 2026, and is solely responsible for the information contained therein.